Browsing by Author "Moore, Kathleen N"
Now showing items 1-3 of 3
-
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Banerjee, Susana; Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N; Oaknin benzaquen, Ana Mazaltob (BMJ, 2020-12-11) -
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, Kathleen N; Oza, Amit M.; Colombo, Nicoletta; Oaknin benzaquen, Ana Mazaltob; Scambia, Giovanni; Lorusso, Domenica (Elsevier, 2021-06) -
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial
Colombo, Nicoletta; Moore, Kathleen N; Scambia, Giovanni; Oaknin benzaquen, Ana Mazaltob; Friedlander, Michael; Lisyanskaya, Alla (Elsevier, 2021-10)